The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
Public ClinicalTrials.gov record NCT04312997. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
Study identification
- NCT ID
- NCT04312997
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pulmotect, Inc.
- Industry
- Enrollment
- 101 participants
Conditions and interventions
Conditions
Interventions
- PUL-042 Inhalation Solution Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 15, 2020
- Primary completion
- Jul 1, 2021
- Completion
- Jul 1, 2021
- Last update posted
- Apr 17, 2023
2020 – 2021
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Irvine | Orange | California | 92868 | — |
| Premeir Urgent Care of California | San Bernardino | California | 92404 | — |
| Clinical Research of South Florida Alliance for Multispecialty Research | Coral Gables | Florida | 33134 | — |
| Invesclinic US LLC | Fort Lauderdale | Florida | 33308 | — |
| DBC Research Corp. | Tamarac | Florida | 33321 | — |
| Affinity Clinical Research, LLC | Tampa | Florida | 33612 | — |
| St. Elizabeth Healthcare | Edgewood | Kentucky | 41017 | — |
| Ascension St. John | Bartlesville | Oklahoma | 74006 | — |
| Ascension St. John | Tulsa | Oklahoma | 74104 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Next Level Urgent Care | Houston | Texas | 77057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04312997, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2023 · Synced Jun 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04312997 live on ClinicalTrials.gov.